| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
125,280,000 |
| Market
Cap: |
4.29(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.16 - $47.08 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 23.1 |
| Insider 6 Months : 24.2 |
| Insider 3/6 Months : 47.5 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Corbus Pharmaceuticals Holdings is focused on the development of immune modulators that will have application in disease states spanning from immuno-oncology to fibrosis. Co.'s pipeline includes anti-integrin monoclonal antibodies that block activation of Transforming growth factor B (TGFB) and small molecules that activate or inhibit the endocannabinoid system. Co.'s pipeline includes: anti-integrin monoclonal antibodies for the treatment of cancer and fibrosis that inhibit the activation of TGFB; cannabinoid receptor type 1 inverse agonists designed to treat obesity and related metabolic diseases; and lenabasum, a synthetic, oral molecule that activates cannabinoid receptor type 2.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
1,300,000 |
1,582,632 |
1,582,632 |
1,633,932 |
| Total Buy Value |
$37,577,560 |
$46,689,501 |
$46,689,501 |
$46,703,200 |
| Total People Bought |
2 |
2 |
2 |
5 |
| Total Buy Transactions |
3 |
4 |
4 |
9 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cormorant Global Healthcare Master Fund, Lp |
|
• • • |
2024-03-08 |
4 |
B |
$41.23 |
$13,314,193 |
I/I |
300,000 |
2,025,000 |
0.01 |
-25% |
|
| Cormorant Global Healthcare Master Fund, Lp |
|
• • • |
2024-03-07 |
4 |
B |
$37.82 |
$10,013,367 |
I/I |
250,000 |
1,725,000 |
0.01 |
-17% |
|
| Smethurst Dominic |
Chief Medical Officer |
• – – |
2024-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
| Moran Sean F. |
Chief Financial Officer |
• – – |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
40,176 |
46,818 |
|
- |
|
| Cohen Yuval |
Chief Executive Officer |
• • – |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
73,947 |
84,400 |
|
- |
|
| Chen Bihua |
|
• • • |
2024-02-02 |
4 |
B |
$19.00 |
$14,250,000 |
I/I |
750,000 |
1,475,000 |
0.01 |
25% |
|
| Chen Bihua |
|
– – • |
2024-01-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
442,368 |
|
14% |
|
| Holmer Alan F |
Director |
– • – |
2024-01-26 |
4 |
OE |
$4.97 |
$3,126 |
D/D |
629 |
1,379 |
|
- |
|
| Chen Bihua |
|
• • • |
2024-01-26 |
4 |
B |
$25.73 |
$9,111,941 |
I/I |
282,632 |
725,000 |
0.01 |
14% |
|
| Cohen Yuval |
Chief Executive Officer |
• • – |
2024-01-26 |
4 |
OE |
$4.97 |
$35,680 |
D/D |
7,179 |
7,179 |
|
- |
|
| Millian Craig Stuart |
Chief Operating Officer |
• – – |
2022-08-10 |
4 |
B |
$0.25 |
$1,273 |
D/D |
5,000 |
27,000 |
2.66 |
-57% |
|
| Cohen Yuval |
Chief Executive Officer |
• • – |
2022-08-10 |
4 |
B |
$0.26 |
$1,003 |
D/D |
3,800 |
98,230 |
2.73 |
-57% |
|
| Moran Sean F. |
Chief Financial Officer |
• – – |
2022-08-10 |
4 |
B |
$0.26 |
$5,198 |
D/D |
20,000 |
199,272 |
2.74 |
-57% |
|
| Moran Sean F. |
Chief Financial Officer |
• – – |
2022-05-16 |
4 |
B |
$0.30 |
$3,600 |
D/D |
12,000 |
179,272 |
2.66 |
-48% |
|
| Cohen Yuval |
Chief Executive Officer |
• • – |
2022-05-16 |
4 |
B |
$0.25 |
$2,625 |
D/D |
10,500 |
94,430 |
2.73 |
-48% |
|
15 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.75 (2.24%) 
